Parkinson’s Disease
Parkinson’s Disease Patient Identification and Education Will Need to Improve When New Disease Modifying Therapies Are Approved, According to Spherix Global Insights
February 16, 2024 10:40 ET | Spherix Global Insights
EXTON, PA, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Millions of people worldwide are affected by Parkinson’s disease (PD), prompting the need for effective disease-modifying therapies (DMTs) to target this...
abvc-logo-nasdaq-440x386 (1).png
ABVC BioPharma Executes a Definitive Agreement to Receive License Fees of $3M and Royalties of 2% on Future Revenues
February 15, 2024 08:30 ET | ABVC BioPharma, Inc.
FREMONT, CA, Feb. 15, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in...
New Logo.png
Provectus Biopharmaceuticals Announces First Quarter 2024 Conference Call
February 15, 2024 08:00 ET | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that it will host a conference call starting at 3...
SightSciences_Logo_2C_RGB.png
Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting
February 14, 2024 16:05 ET | Sight Sciences, Inc.
MENLO PARK, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing...
Global Artificial Eye Market
Artificial Eye Market Poised for Remarkable Growth: Detailed Analysis of Types, Materials, and Forecasts through 2030
February 14, 2024 11:29 ET | Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Artificial Eye Market by Type (Conformer, Flush Shells, Orbital Prosthesis), Material (Acrylic, Porcelain, Silicone), Indication, End-User -...
Global Fundus Cameras Market
Global Fundus Cameras Market Set for Expansion, Forecasted to Achieve Significant Growth by 2030
February 14, 2024 11:26 ET | Research and Markets
Dublin, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The "Global Fundus Cameras Market by Product (Hybrid Fundus Cameras, Mydriatic Fundus Cameras, Nonmydriatic Fundus Cameras), End User (Hospitals, Ophthalmic...
logo.png
Ashvattha Therapeutics to Participate in Upcoming Investor Conferences
February 14, 2024 08:30 ET | Ashvattha Therapeutics
REDWOOD CITY, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Ashvattha Therapeutics (“Ashvattha”), a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue...
New Logo.png
Provectus Biopharmaceuticals Engages irlabs for Investor Relations Services
February 14, 2024 08:00 ET | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT) today announced that it has engaged IR Labs, Inc. (“irlabs”) to...
LOGO-PNG.png
Ocuphire Pharma Strengthens Leadership Team with Key Appointments
February 14, 2024 08:00 ET | Ocuphire Pharma
Ash Jayagopal, Ph.D., M.B.A. Appointed Chief Scientific and Development Officer Nirav Jhaveri, C.F.A, M.B.A. Appointed as Chief Financial Officer FARMINGTON HILLS, Mich., Feb. 14, 2024 (GLOBE...
ocugen_4C_LOGO (002).png
Ocugen to Host Clinical Showcase in New York City on Wednesday, February 21, 2024
February 14, 2024 07:30 ET | Ocugen
Highlighting updates on OCU400 Phase 3 clinical trial starting early 2024 Featuring thought leaders in gene therapy and OCU400 Phase 1/2 clinical trial patient MALVERN, Pa., Feb. 14, 2024 ...